Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: Correlations with clinical data

Cancer Biomarkers

Volumn 14, Issue 2-3, 2014, Pages 185-194

  Chiorean, Roxana ^a,b   Berindan Neagoe, Ioana ^a,c   Braicu, Cornelia ^a,c   Florian, Ioan Stefan ^a   Leucuta, Daniel ^a   Crisan, Doinita ^a   Cernea, Valentin ^a,c  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF FREIBURG   (Germany)

^c THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

Author keywords

angiogenesis; ELISA; Glioblastoma multiforme; histopathology; inflammation; survival rates

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; IL6 PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GANGRENE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INFLAMMATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SURVIVAL RATE; TUMOR NECROSIS; BLOOD; BRAIN TUMOR; CASE CONTROL STUDY; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY; PREDICTIVE VALUE;

BIOMARKERS; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; GLIOBLASTOMA; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; INTERLEUKIN-8; NEOVASCULARIZATION, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-SIS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904278479     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130310     Document Type: Article

References (33)

1. S.I. Abdulrauf, K. Edvardsen, K.L. Ho, X.Y. Yang, J.P. Rock and M.L. Rosenblum, Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma, J Neurosurg 88 (1998), 513-20.
2. J.C. Anderson, B.C. McFarland and C.L. Gladson, New molecular targets in angiogenic vessels of glioblastoma tumors, Expert Rev Mol Med 10 (2008), e23.
3. I. Berindan-Neagoe, R. Chiorean, C. Braicu, I.S. Florian, D. Leucuta, D. Crisan, A. Cocis, O. Balacescu and A. Irimie, Quantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: lack of correlation with clinical data, Eur Cytokine Netw 23 (2012), 45-55.
4. C. Choi, G.Y. Gillespie, N.J. Van Wagoner and E.N. Benveniste, Fas engagement increases expression of interleukin 6 in human glioma cells, J Neurooncol 56 (2002), 13-9.
5. A. Claes, A.J. Idema and P. Wesseling, Diffuse glioma growth: a guerilla war, Acta Neuropathol 114 (2007), 443-58.
6. M. Dews, J.L. Fox, S. Hultine, P. Sundaram, W. Wang, Y. Liu, E. Furth, G. Enders, W. El-Deiry, J.M. Schelter, M.A. Cleary and A.T. Tikhonenko, Myc - miR-17~92 axis blunts TGFβ signaling and production ofmultiple TGFβ-dependent anti-angiogenic factors, Cancer Res 70 (2010), 8233-8246.
7. A.M. Fernandez and I. Torres-Alemán, The many faces of insulin-like peptide signalling in the brain, Nat Rev Neurosci 13 (2012), 225-39.
8. D. Figarella-Branger, C. Bouvier, J. Moroch, S. Michalak and F. Burel-Vandenbos, [Morphological classification of glioblastomas], Neurochirurgie 56 (2010), 459-63.
9. R. Francescone, S. Scully, B. Bentley, W. Yan, S.L. Taylor, D. Oh, L. Moral and R. Shao, Glioblastoma-Derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Activation, J Biol Chem 287(2012), 24821-31.
10. S. Freitas, S. Costa, C. Azevedo, G. Carvalho, S. Freire, P. Barbosa, E. Velozo, R. Schaer, M. Tardy, R. Meyer and I. Nascimento, Flavonoids Inhibit Angiogenic Cytokine Production by Human Glioma Cells, Phytother Res 25 (2011), 916-921.
11. D. Háerstrand, M.B. Lindh, C. Peñ, C. Garcia-Echeverria, M. Nistér, F. Hofmann and A. Ostman, PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541, Neuro Oncol 12 (2010), 967-75.
12. O. Kargiotis, J.S. Rao and A.P. Kyritsis, Mechanisms of angiogenesis in gliomas, J Neurooncol 8 (2006), 281-93.
13. R.E. Kast, F. Lefranc, G. Karpel-Massler and M.E. Halatsch, Why dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma, Br J Neurosurg 26 (2012), 813-7.
14. D. Kesanakurti, C. Chetty, P. Bhoopathi, S.S. Lakka, B. Gorantla, A.J. Tsung and J.S. Rao, Suppression of MMP-2 Attenuates TNF-alpha Induced NF-kB Activation and Leads to JNK Mediated Cell Death in Glioma, PLoS One 6 (2011), e19341.
15. J. Lohr, T. Ratliff, A. Huppertz, Y. Ge, C. Dictus, R. Ahmadi, S. Grau, N. Hiraoka, V. Eckstein, R.C. Ecker, T. Korff, A. von Deimling, A. Unterberg, P. Beckhove and C. Herold-Mende, Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β, Clin Cancer Res 17 (2011), 4296-4308.
16. I. Nazarenko, A. Hedrén, H. Sjödin, A. Orrego, J. Andrae, G.B. Afink, M. Nistér and M.S. Lindström, Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells, PLoS One 6 (2011), e18303.
17. D.R. Premkumar, E.P. Jane and I.F. Pollack, Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines, Int J Oncol 37 (2010), 633-43.
18. B. Raychaudhuri and M.A. Vogelbaum, IL-8 is a mediator of NF-κB induced invasion by gliomas, J Neurooncol 101 (2011), 227-35.
19. G. Reynés, V. Vila, M. Martín, A. Parada, T. Fleitas, E. Reganon and V. Martínez-Sales, Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma, J Neurooncol 102 (2011), 35-41.
20. Y. Rong, D.L. Durden, E.G. Van Meir and D.J. Brat, " Pseudopalisading" necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis, J Neuropathol Exp Neurol 65 (2006), 529-39.
21. S. Sakuma, Y. Sawamura, M. Tada, T. Aida, H. Abe, K. Suzuki and N. Taniguchi, Responses of human glioblastoma cells to human natural tumor necrosis factor-alpha: susceptibility, mechanism of resistance and cytokine production studies, J Neurooncol 15 (1993), 197-208.
22. V. Samaras, C. Piperi, P. Korkolopoulou, A. Zisakis, G. Levidou, M.S. Themistocleous, E.I. Boviatsis, D.E. Sakas, R.W. Lea, A. Kalofoutis and E. Patsouris, Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL10 secretion in peripheral blood of patients with astroglial tumors, Mol Cell Biochem 304 (2007), 343-51.
23. V. Samaras, C. Piperi, G. Levidou, A. Zisakis, N. Kavantzas, M.S. Themistocleous, E.I. Boviatsis, C. Barbatis, R.W. Lea, A. Kalofoutis and P. Korkolopoulou, Analysis of interleukin (IL)-8 expression in human astrocytomas: Associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor and microvessel morphometry, Hum Immunol 70 (2009), 391-7.
24. T.N. Seyfried, J. Marsh, L.M. Shelton, L.C. Huysentruyt and P. Mukherjee, Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?, Epilepsy Res 100 (2012), 310-26.
25. T.N. Showalter, J. Andrel, D.W. Andrews, W.J. Jr. Curran, C. Daskalakis and M. Werner-Wasik, Multifocal Glioblastoma Multiforme: Prognostic Factors and Patterns of Progression, Int J Radiat Oncol Biol Phys 69 (2007), 820-4.
26. S. Sinha, N. Koul, D. Dixit, V. Sharma and E. Sen, IGF-1 induced HIF-1α-TLR9 cross talk regulates inflammatory responses in glioma, Cell Signal 23 (2011), 1869-75.
27. M. Tada, [In vitro and in vivo immunobiological responses of glioblastoma to human natural tumor necrosis factor-alpha], Hokkaido Igaku Zasshi 67 (1992), 498-511.
28. J. Trojan, J.F. Cloix, M.Y. Ardourel, M. Chatel and D.D. Anthony, Insulin-like growth factor type I biology and targeting in malignant gliomas, Neuroscience 145 (2007), 795-811.
29. J. Trojan, A. Ly, M.X. Wei, M. Bierwagen, P. Kopinski, Y. Pan, M.Y. Ardourel, T. Dufour, A. Shevelev, L.A. Trojan, J.C. François, C. Andres, T. Popiela, M. Chatel, H. Kasprzak, D.D. Anthony and H.T. Duc, Antisense anti IGF-I cellular therapy of malignant tumors: immune response in cancer patients, Biomed Pharmacother 64 (2010), 576-8.
30. J. Wang, A. Razuvaev, L. Folkersen, E. Hedin, J. Roy, K. Brismar and U. Hedin, The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation, Atherosclerosis 220 (2012), 102-9.
31. A. Wesolowska, A. Kwiatkowska, L. Slomnicki, M. Dembinski, A. Master, M. Sliwa, K. Franciszkiewicz, S. Chouaib and B. Kaminska, Microglia-derived TGF-b as an important regulator of glioblastoma invasion - an inhibition of TGF-bdependent effects by shRNA against human TGF-b type II receptor, Oncogene 27 (2008), 918-930.
32. A. Zisakis, C. Piperi, M.S. Themistocleous, P. Korkolopoulou, E.I. Boviatsis, D.E. Sakas, E. Patsouris, R.W. Lea and A. Kalofoutis, Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients, Cytokine 39 (2007), 99-105.
33. W. Zundel, C. Schindler, D. Haas-Kogan, A. Koong, F. Kaper, E. Chen, A.R. Gottschalk, H.E. Ryan, R.S. Johnson, A.B. Jefferson, D. Stokoe and A.J. Giaccia, Loss of PTEN facilitates HIF-1-mediated gene expression, Genes Dev 14 (2000), 391-6.